The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
Researchers are conducting the first clinical trial to examine how selective estrogen receptor modulators’ (SERMs) may help both men and women suffering from schizophrenia.
A new research program will target biological causes and possible treatments, including anti-psychotic drugs, brain stimulation and hormones.
Dummy text
